Stroke Prevention in Atrial Fibrillation

ACCP Stroke Prevention in Atrial Fibrillation

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/55271

Contents of this Issue

Navigation

Page 7 of 7

Grading System Strength of Recommendation Grade 1 = stronga Grade 2 = weakerb a Quality of Evidence A = high B = moderate C = low Grade 1 recommendations are strong and indicate that the benefits do, or do not, outweigh risks, burden, and costs. b Grade 2 suggests that individual patient values may lead to different choices. Abbreviations ACCP, American College of Chest Physicians; ACS, acute coronary syndrome; AF, atrial fibrillation; APTT, activated partial thromboplastin time; bid, twice a day; BMS, bare-metal stent; CAD, coronary artery disease; CHADS2 , congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischemic attack; DES, drug-eluting stent; DVT, deep venous thrombosis; FDA, US Food and Drug Administration; INR, international normalized ratio; IV, intravenous; LMWH, low-molecular-weight heparin; MI, myocardial infarction; PO, by mouth; Rx, prescription; subcut, subcutaneous; STEMI, ST-segment elevation myocardial infarction; TEE, transesophageal echocardiography; UFH, unfractionated heparin; VKA, vitamin K antagonist Source You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S-e575S. doi:10.1378/chest.11-2304. Disclaimer This Guideline attempts to define principles of practice that should produce high-quality patient care. It focuses on the needs of primary care practice, but also is applicable to providers at all levels. This Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgement concerning the propriety of any course of conduct must be made by the clinician aſter consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool. STR02122f 5740 Executive Drive Suite 218 Baltimore, MD 21228 TEL: 410-869-3332 • FAX: 410-744-2150 For additional copies: orders@GuidelineCentral.com Copyright © 2012 All rights reserved

Articles in this issue

Links on this page

Archives of this issue

view archives of Stroke Prevention in Atrial Fibrillation - ACCP Stroke Prevention in Atrial Fibrillation